Skip to main content
. 2023 Mar 9;114(6):2460–2470. doi: 10.1111/cas.15765

FIGURE 3.

FIGURE 3

Effects of sclerostin inhibition on tumor growth in the orthotopic mammary fat pads. (A–C) Effects of the anti‐sclerostin antibody (Ab) on the growth of 4T1 (A, n = 5), E0771/Bone (B, n = 6), and MDA‐MB‐231 (C, n = 8) tumors in the mammary fat pads. (D) Tumor growth of E0771/Bone in the mammary fat pads in Sost‐deficient mice (n = 8). Data are expressed as tumor volume (mm3). *p < 0.05.